Erythropoietin Nanobots: Their Feasibility for the Controlled Release of Erythropoietin and Their Neuroprotective Bioequivalence in Central Nervous System Injury

Erythropoietin Nanobots: Their Feasibility for the Controlled Release of Erythropoietin and Their Neuroprotective Bioequivalence in Central Nervous System Injury

Background: Erythropoietin (EPO) plays important roles in neuroprotection in central nervous system injury. Due to the limited therapeutic time window and coexistence of hematopoietic/extrahematopoietic receptors displaying heterogenic and phylogenetic differences, fast, targeted delivery agents, su...

Full description

Bibliographic Details
Main Authors: Thi Huong Le, Chanh Trung Nguyen, Kyo-in Koo, Chang Ho Hwang
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Applied Sciences
Subjects:
nanoparticles
erythropoietin
polymers
therapeutics
regeneration
central nervous system
Online Access:https://www.mdpi.com/2076-3417/12/7/3351

Internet

https://www.mdpi.com/2076-3417/12/7/3351

Similar Items